

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 4.84826813 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 4.84826813 |
| 3 | protein localization to endosome (GO:0036010) | 3.89810046 |
| 4 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.55813111 |
| 5 | skin morphogenesis (GO:0043589) | 3.53219895 |
| 6 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.46161066 |
| 7 | regulation of early endosome to late endosome transport (GO:2000641) | 3.33200640 |
| 8 | regulation of extracellular matrix disassembly (GO:0010715) | 3.27228676 |
| 9 | barbed-end actin filament capping (GO:0051016) | 3.24762438 |
| 10 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.22244194 |
| 11 | protein retention in ER lumen (GO:0006621) | 3.22065345 |
| 12 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.13310823 |
| 13 | vesicle coating (GO:0006901) | 3.06896653 |
| 14 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.93483204 |
| 15 | iron ion import (GO:0097286) | 2.86522853 |
| 16 | positive regulation of receptor recycling (GO:0001921) | 2.85793266 |
| 17 | positive regulation of extracellular matrix organization (GO:1903055) | 2.85668941 |
| 18 | negative regulation of fatty acid transport (GO:2000192) | 2.82672196 |
| 19 | extracellular fibril organization (GO:0043206) | 2.81625982 |
| 20 | hypotonic response (GO:0006971) | 2.79433869 |
| 21 | macroautophagy (GO:0016236) | 2.79116301 |
| 22 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.77603579 |
| 23 | cell adhesion mediated by integrin (GO:0033627) | 2.77347189 |
| 24 | stress fiber assembly (GO:0043149) | 2.73706549 |
| 25 | fibril organization (GO:0097435) | 2.70400223 |
| 26 | type B pancreatic cell proliferation (GO:0044342) | 2.68959577 |
| 27 | cell-substrate junction assembly (GO:0007044) | 2.68004013 |
| 28 | regulation of ARF protein signal transduction (GO:0032012) | 2.67427736 |
| 29 | protein targeting to plasma membrane (GO:0072661) | 2.65619897 |
| 30 | mannose metabolic process (GO:0006013) | 2.64656251 |
| 31 | COPII vesicle coating (GO:0048208) | 2.60864104 |
| 32 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.60658114 |
| 33 | extracellular matrix assembly (GO:0085029) | 2.59269814 |
| 34 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.58198117 |
| 35 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.57498815 |
| 36 | cortical actin cytoskeleton organization (GO:0030866) | 2.57082783 |
| 37 | focal adhesion assembly (GO:0048041) | 2.53761512 |
| 38 | cell-substrate adherens junction assembly (GO:0007045) | 2.53761512 |
| 39 | peptidyl-proline hydroxylation (GO:0019511) | 2.52970016 |
| 40 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.51617261 |
| 41 | basement membrane organization (GO:0071711) | 2.51301210 |
| 42 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.49633960 |
| 43 | apoptotic cell clearance (GO:0043277) | 2.48013400 |
| 44 | collagen fibril organization (GO:0030199) | 2.46769736 |
| 45 | adherens junction assembly (GO:0034333) | 2.45641520 |
| 46 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.42368010 |
| 47 | positive regulation of nuclease activity (GO:0032075) | 2.39980256 |
| 48 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.39539162 |
| 49 | protein hydroxylation (GO:0018126) | 2.39469393 |
| 50 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.38289667 |
| 51 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.35566691 |
| 52 | regulation of extracellular matrix organization (GO:1903053) | 2.34912590 |
| 53 | response to laminar fluid shear stress (GO:0034616) | 2.34600870 |
| 54 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.34236003 |
| 55 | adhesion of symbiont to host (GO:0044406) | 2.34180917 |
| 56 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.31328458 |
| 57 | actin filament depolymerization (GO:0030042) | 2.29851994 |
| 58 | cellular response to monoamine stimulus (GO:0071868) | 2.29185057 |
| 59 | cellular response to catecholamine stimulus (GO:0071870) | 2.29185057 |
| 60 | positive regulation of osteoblast proliferation (GO:0033690) | 2.28843572 |
| 61 | import into cell (GO:0098657) | 2.28431855 |
| 62 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.27546856 |
| 63 | cortical cytoskeleton organization (GO:0030865) | 2.26737800 |
| 64 | low-density lipoprotein particle clearance (GO:0034383) | 2.25114734 |
| 65 | gas transport (GO:0015669) | 2.25064459 |
| 66 | alpha-linolenic acid metabolic process (GO:0036109) | 2.24151430 |
| 67 | response to thyroid hormone (GO:0097066) | 2.22917694 |
| 68 | cellular response to epinephrine stimulus (GO:0071872) | 2.22573602 |
| 69 | regulation of cholesterol homeostasis (GO:2000188) | 2.21916719 |
| 70 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.20877588 |
| 71 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.19444575 |
| 72 | ER-nucleus signaling pathway (GO:0006984) | 2.18006879 |
| 73 | positive regulation of protein dephosphorylation (GO:0035307) | 2.17953585 |
| 74 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.17536255 |
| 75 | desmosome organization (GO:0002934) | 2.16277756 |
| 76 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.15748640 |
| 77 | cell volume homeostasis (GO:0006884) | 2.15663324 |
| 78 | sodium ion export (GO:0071436) | 2.14417740 |
| 79 | virion attachment to host cell (GO:0019062) | 2.13533854 |
| 80 | adhesion of symbiont to host cell (GO:0044650) | 2.13533854 |
| 81 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.13432788 |
| 82 | cellular response to unfolded protein (GO:0034620) | 2.12447368 |
| 83 | protein heterotrimerization (GO:0070208) | 2.12053324 |
| 84 | negative regulation of cell size (GO:0045792) | 2.09033140 |
| 85 | regulation of response to osmotic stress (GO:0047484) | 2.08891980 |
| 86 | negative regulation of anoikis (GO:2000811) | 2.06474369 |
| 87 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.04911004 |
| 88 | surfactant homeostasis (GO:0043129) | 2.03305103 |
| 89 | endodermal cell differentiation (GO:0035987) | 2.02319581 |
| 90 | venous blood vessel morphogenesis (GO:0048845) | 2.02073329 |
| 91 | positive regulation of myotube differentiation (GO:0010831) | 2.00792410 |
| 92 | regulation of cholesterol metabolic process (GO:0090181) | 1.99792381 |
| 93 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 1.99771980 |
| 94 | hyaluronan catabolic process (GO:0030214) | 1.99746841 |
| 95 | regulation of nuclease activity (GO:0032069) | 1.99736802 |
| 96 | hemoglobin metabolic process (GO:0020027) | 1.99379869 |
| 97 | hemidesmosome assembly (GO:0031581) | 1.97965596 |
| 98 | negative regulation of complement activation (GO:0045916) | 1.97814350 |
| 99 | collagen metabolic process (GO:0032963) | 1.97440608 |
| 100 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 1.96865424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.29400995 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.09335302 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.92015092 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.69218364 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.60054351 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.51517195 |
| 7 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.22565939 |
| 8 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.13300980 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.12184941 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.10749835 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.08081713 |
| 12 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.05258822 |
| 13 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05020539 |
| 14 | GATA1_19941826_ChIP-Seq_K562_Human | 2.03052625 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.02631043 |
| 16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.97421870 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.89602891 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88837270 |
| 19 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.87024889 |
| 20 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.81778363 |
| 21 | KDM2B_26808549_Chip-Seq_K562_Human | 1.80368777 |
| 22 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.80151105 |
| 23 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.79756533 |
| 24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.72584798 |
| 25 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.71298906 |
| 26 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.71222119 |
| 27 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.71222119 |
| 28 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.62857215 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.62818625 |
| 30 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.62320165 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62084125 |
| 32 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.61967295 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.61650393 |
| 34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.60511209 |
| 35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.59104563 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57672712 |
| 37 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.56710984 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56190634 |
| 39 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52075299 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51264353 |
| 41 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.51182678 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47890555 |
| 43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.46974118 |
| 44 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.46551384 |
| 45 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.45197946 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.41406309 |
| 47 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.41047484 |
| 48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.39313896 |
| 49 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.37376098 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35238952 |
| 51 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.35030802 |
| 52 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.34384696 |
| 53 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.30709915 |
| 54 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.30398745 |
| 55 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29809775 |
| 56 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.29665652 |
| 57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28805099 |
| 58 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28226066 |
| 59 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27702566 |
| 60 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27346540 |
| 61 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.26248304 |
| 62 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.24739179 |
| 63 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24452366 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.24416049 |
| 65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.24324305 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23643163 |
| 67 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21938070 |
| 68 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.21921674 |
| 69 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.21370833 |
| 70 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.20969567 |
| 71 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20486730 |
| 72 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15417721 |
| 73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14133140 |
| 74 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14029429 |
| 75 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11591646 |
| 76 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11159951 |
| 77 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.09845682 |
| 78 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09469319 |
| 79 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09191975 |
| 80 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.07836664 |
| 81 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.07836664 |
| 82 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06398757 |
| 83 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04966594 |
| 84 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04961027 |
| 85 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.04774639 |
| 86 | MYC_22102868_ChIP-Seq_BL_Human | 1.03648255 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.03494466 |
| 88 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03239843 |
| 89 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03222688 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02735827 |
| 91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02195714 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02033846 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01113195 |
| 94 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.00980456 |
| 95 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.00480960 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00190178 |
| 97 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.99618244 |
| 98 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99268951 |
| 99 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99125747 |
| 100 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98524890 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.59717068 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 4.41321122 |
| 3 | MP0001958_emphysema | 2.91270936 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.81947415 |
| 5 | MP0005451_abnormal_body_composition | 2.81000256 |
| 6 | MP0005275_abnormal_skin_tensile | 2.78601240 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.77410310 |
| 8 | MP0002877_abnormal_melanocyte_morpholog | 2.76263760 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.64224034 |
| 10 | MP0003566_abnormal_cell_adhesion | 2.64008626 |
| 11 | MP0009840_abnormal_foam_cell | 2.51233130 |
| 12 | MP0005503_abnormal_tendon_morphology | 2.44132573 |
| 13 | MP0003279_aneurysm | 2.41365901 |
| 14 | MP0004272_abnormal_basement_membrane | 2.39622587 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.32130558 |
| 16 | MP0003329_amyloid_beta_deposits | 2.13885438 |
| 17 | MP0000751_myopathy | 2.13184146 |
| 18 | MP0003091_abnormal_cell_migration | 2.01215305 |
| 19 | MP0003656_abnormal_erythrocyte_physiolo | 1.90675547 |
| 20 | MP0003172_abnormal_lysosome_physiology | 1.76231819 |
| 21 | MP0005409_darkened_coat_color | 1.74955404 |
| 22 | MP0005257_abnormal_intraocular_pressure | 1.64838150 |
| 23 | MP0008260_abnormal_autophagy | 1.45352696 |
| 24 | MP0000604_amyloidosis | 1.43797096 |
| 25 | MP0002060_abnormal_skin_morphology | 1.43262381 |
| 26 | MP0002896_abnormal_bone_mineralization | 1.41982807 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 1.41652547 |
| 28 | MP0004233_abnormal_muscle_weight | 1.41135874 |
| 29 | MP0000747_muscle_weakness | 1.39559068 |
| 30 | MP0004858_abnormal_nervous_system | 1.38132148 |
| 31 | MP0005023_abnormal_wound_healing | 1.35058223 |
| 32 | MP0004084_abnormal_cardiac_muscle | 1.33746568 |
| 33 | MP0003045_fibrosis | 1.31268137 |
| 34 | MP0000003_abnormal_adipose_tissue | 1.26300830 |
| 35 | MP0004036_abnormal_muscle_relaxation | 1.20509130 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.19715991 |
| 37 | MP0000767_abnormal_smooth_muscle | 1.15874715 |
| 38 | MP0000013_abnormal_adipose_tissue | 1.15357639 |
| 39 | MP0002295_abnormal_pulmonary_circulatio | 1.14444263 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.13751973 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.13232864 |
| 42 | MP0003690_abnormal_glial_cell | 1.12662702 |
| 43 | MP0005076_abnormal_cell_differentiation | 1.11108007 |
| 44 | MP0004130_abnormal_muscle_cell | 1.10985312 |
| 45 | MP0005165_increased_susceptibility_to | 1.08747295 |
| 46 | MP0004510_myositis | 1.08598959 |
| 47 | MP0000759_abnormal_skeletal_muscle | 1.07590489 |
| 48 | MP0000920_abnormal_myelination | 1.06773257 |
| 49 | MP0003436_decreased_susceptibility_to | 1.06237317 |
| 50 | MP0006138_congestive_heart_failure | 1.05401033 |
| 51 | MP0004087_abnormal_muscle_fiber | 1.04633355 |
| 52 | MP0006054_spinal_hemorrhage | 1.03093335 |
| 53 | MP0000678_abnormal_parathyroid_gland | 1.02322431 |
| 54 | MP0002971_abnormal_brown_adipose | 1.00795889 |
| 55 | MP0005164_abnormal_response_to | 1.00645333 |
| 56 | MP0001348_abnormal_lacrimal_gland | 1.00481888 |
| 57 | MP0001542_abnormal_bone_strength | 1.00113981 |
| 58 | MP0002269_muscular_atrophy | 0.99955044 |
| 59 | MP0005375_adipose_tissue_phenotype | 0.99654484 |
| 60 | MP0003828_pulmonary_edema | 0.99354168 |
| 61 | MP0002108_abnormal_muscle_morphology | 0.97539455 |
| 62 | MP0003634_abnormal_glial_cell | 0.96586984 |
| 63 | MP0002998_abnormal_bone_remodeling | 0.95667714 |
| 64 | MP0003075_altered_response_to | 0.95167431 |
| 65 | MP0000749_muscle_degeneration | 0.94224417 |
| 66 | MP0005330_cardiomyopathy | 0.94114782 |
| 67 | MP0001915_intracranial_hemorrhage | 0.93052069 |
| 68 | MP0000733_abnormal_muscle_development | 0.91472235 |
| 69 | MP0004947_skin_inflammation | 0.90717657 |
| 70 | MP0000681_abnormal_thyroid_gland | 0.90515952 |
| 71 | MP0005623_abnormal_meninges_morphology | 0.89221970 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 0.87989086 |
| 73 | MP0001849_ear_inflammation | 0.87508546 |
| 74 | MP0001243_abnormal_dermal_layer | 0.86233517 |
| 75 | MP0004883_abnormal_blood_vessel | 0.85322658 |
| 76 | MP0001533_abnormal_skeleton_physiology | 0.85064095 |
| 77 | MP0010630_abnormal_cardiac_muscle | 0.84789170 |
| 78 | MP0001299_abnormal_eye_distance/ | 0.83614344 |
| 79 | MP0000858_altered_metastatic_potential | 0.83458006 |
| 80 | MP0003303_peritoneal_inflammation | 0.83105926 |
| 81 | MP0005083_abnormal_biliary_tract | 0.82542895 |
| 82 | MP0000343_altered_response_to | 0.80818323 |
| 83 | MP0005666_abnormal_adipose_tissue | 0.80757839 |
| 84 | MP0004859_abnormal_synaptic_plasticity | 0.76659427 |
| 85 | MP0005508_abnormal_skeleton_morphology | 0.76373709 |
| 86 | MP0003879_abnormal_hair_cell | 0.75766552 |
| 87 | MP0002168_other_aberrant_phenotype | 0.74801249 |
| 88 | MP0009384_cardiac_valve_regurgitation | 0.74660543 |
| 89 | MP0003959_abnormal_lean_body | 0.73734039 |
| 90 | MP0008004_abnormal_stomach_pH | 0.73559365 |
| 91 | MP0003795_abnormal_bone_structure | 0.72403816 |
| 92 | MP0003868_abnormal_feces_composition | 0.71718529 |
| 93 | MP0005621_abnormal_cell_physiology | 0.70837079 |
| 94 | MP0001661_extended_life_span | 0.68752556 |
| 95 | MP0002972_abnormal_cardiac_muscle | 0.68384871 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 0.65929898 |
| 97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65250617 |
| 98 | MP0003183_abnormal_peptide_metabolism | 0.64468746 |
| 99 | MP0005390_skeleton_phenotype | 0.64204492 |
| 100 | MP0005595_abnormal_vascular_smooth | 0.64112982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.82352859 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.38189815 |
| 3 | Vascular tortuosity (HP:0004948) | 3.61176988 |
| 4 | Arterial tortuosity (HP:0005116) | 3.44927486 |
| 5 | Aortic aneurysm (HP:0004942) | 3.19501954 |
| 6 | Aortic dissection (HP:0002647) | 3.11819111 |
| 7 | Vertebral compression fractures (HP:0002953) | 3.09478759 |
| 8 | Cerebral aneurysm (HP:0004944) | 2.99248575 |
| 9 | Polycythemia (HP:0001901) | 2.92315938 |
| 10 | Dilatation of the ascending aorta (HP:0005111) | 2.77526552 |
| 11 | Increased connective tissue (HP:0009025) | 2.72723484 |
| 12 | Increased variability in muscle fiber diameter (HP:0003557) | 2.70528955 |
| 13 | Mitral stenosis (HP:0001718) | 2.62871060 |
| 14 | Bladder diverticulum (HP:0000015) | 2.62225294 |
| 15 | Wormian bones (HP:0002645) | 2.58035500 |
| 16 | Aneurysm (HP:0002617) | 2.57801256 |
| 17 | Fragile skin (HP:0001030) | 2.46833210 |
| 18 | Asymmetric septal hypertrophy (HP:0001670) | 2.44679980 |
| 19 | Atrophic scars (HP:0001075) | 2.43441726 |
| 20 | Spinal rigidity (HP:0003306) | 2.39792969 |
| 21 | Cervical subluxation (HP:0003308) | 2.34185503 |
| 22 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.33537100 |
| 23 | Type 1 muscle fiber predominance (HP:0003803) | 2.31487674 |
| 24 | Mitral regurgitation (HP:0001653) | 2.30712882 |
| 25 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.29855796 |
| 26 | Osteolytic defects of the hand bones (HP:0009699) | 2.29855796 |
| 27 | Dysostosis multiplex (HP:0000943) | 2.29495066 |
| 28 | Soft skin (HP:0000977) | 2.26685387 |
| 29 | Neurofibrillary tangles (HP:0002185) | 2.25812022 |
| 30 | Distal upper limb amyotrophy (HP:0007149) | 2.23239966 |
| 31 | Upper limb amyotrophy (HP:0009129) | 2.23239966 |
| 32 | Mucopolysacchariduria (HP:0008155) | 2.22926825 |
| 33 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.22926825 |
| 34 | Blue sclerae (HP:0000592) | 2.17596573 |
| 35 | Cholecystitis (HP:0001082) | 2.17007917 |
| 36 | Abnormal gallbladder physiology (HP:0012438) | 2.17007917 |
| 37 | Reticulocytosis (HP:0001923) | 2.16743155 |
| 38 | Peritonitis (HP:0002586) | 2.16112357 |
| 39 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.14867059 |
| 40 | Short nail (HP:0001799) | 2.14646768 |
| 41 | Insomnia (HP:0100785) | 2.12929515 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 2.11190611 |
| 43 | Hyperextensible skin (HP:0000974) | 2.11008577 |
| 44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10543345 |
| 45 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10543345 |
| 46 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10543345 |
| 47 | Deep venous thrombosis (HP:0002625) | 2.07493128 |
| 48 | Hyporeflexia of lower limbs (HP:0002600) | 2.07353445 |
| 49 | Ankle contracture (HP:0006466) | 2.06212675 |
| 50 | Hyperacusis (HP:0010780) | 2.00249782 |
| 51 | Hand muscle atrophy (HP:0009130) | 1.99110613 |
| 52 | Mitral valve prolapse (HP:0001634) | 1.98443032 |
| 53 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.97062006 |
| 54 | Shallow orbits (HP:0000586) | 1.96445549 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 1.95452367 |
| 56 | Joint laxity (HP:0001388) | 1.94867305 |
| 57 | Abnormality of complement system (HP:0005339) | 1.94342995 |
| 58 | Ankyloglossia (HP:0010296) | 1.94116074 |
| 59 | Spondylolisthesis (HP:0003302) | 1.93143790 |
| 60 | Interstitial pulmonary disease (HP:0006530) | 1.89584675 |
| 61 | Obstructive sleep apnea (HP:0002870) | 1.88722493 |
| 62 | Disproportionate tall stature (HP:0001519) | 1.87131128 |
| 63 | Distal lower limb amyotrophy (HP:0008944) | 1.86627274 |
| 64 | Atelectasis (HP:0100750) | 1.83590214 |
| 65 | Venous abnormality (HP:0002624) | 1.81690146 |
| 66 | Abnormality of the acetabulum (HP:0003170) | 1.81292178 |
| 67 | Broad metatarsal (HP:0001783) | 1.80625496 |
| 68 | Supranuclear gaze palsy (HP:0000605) | 1.78092782 |
| 69 | Exercise-induced myalgia (HP:0003738) | 1.77302207 |
| 70 | Asymmetry of the thorax (HP:0001555) | 1.77109064 |
| 71 | Complement deficiency (HP:0004431) | 1.73871386 |
| 72 | Broad face (HP:0000283) | 1.73806431 |
| 73 | Ovoid vertebral bodies (HP:0003300) | 1.72658342 |
| 74 | Follicular hyperkeratosis (HP:0007502) | 1.72292292 |
| 75 | Ulnar bowing (HP:0003031) | 1.72032680 |
| 76 | Skin nodule (HP:0200036) | 1.71370665 |
| 77 | Striae distensae (HP:0001065) | 1.71355135 |
| 78 | Abnormality of oral frenula (HP:0000190) | 1.71261204 |
| 79 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.70546632 |
| 80 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.70546632 |
| 81 | Abnormality of glycolipid metabolism (HP:0010969) | 1.70546632 |
| 82 | Slender build (HP:0001533) | 1.68556202 |
| 83 | Abnormality of the tricuspid valve (HP:0001702) | 1.67659538 |
| 84 | Neonatal short-limb short stature (HP:0008921) | 1.67454576 |
| 85 | Overgrowth (HP:0001548) | 1.65925596 |
| 86 | Abnormality of carpal bone ossification (HP:0006257) | 1.65377852 |
| 87 | Hypoplasia of the iris (HP:0007676) | 1.63960399 |
| 88 | Biconcave vertebral bodies (HP:0004586) | 1.63920577 |
| 89 | Genu recurvatum (HP:0002816) | 1.63163856 |
| 90 | Achilles tendon contracture (HP:0001771) | 1.62997923 |
| 91 | Hammertoe (HP:0001765) | 1.62621437 |
| 92 | Thin bony cortex (HP:0002753) | 1.62366033 |
| 93 | Thin skin (HP:0000963) | 1.62341518 |
| 94 | Decreased motor nerve conduction velocity (HP:0003431) | 1.62156215 |
| 95 | Vertebral arch anomaly (HP:0008438) | 1.60665385 |
| 96 | Coxa vara (HP:0002812) | 1.59605124 |
| 97 | Abnormal delivery (HP:0001787) | 1.57919754 |
| 98 | Foot dorsiflexor weakness (HP:0009027) | 1.57887287 |
| 99 | Cholelithiasis (HP:0001081) | 1.57480755 |
| 100 | Hyperparathyroidism (HP:0000843) | 1.56581952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.77121424 |
| 2 | ERN1 | 3.08901492 |
| 3 | PRPF4B | 3.01669224 |
| 4 | ICK | 2.46467120 |
| 5 | RIPK1 | 2.45839043 |
| 6 | KSR2 | 2.41174561 |
| 7 | PDGFRA | 2.36671414 |
| 8 | TTN | 1.96250874 |
| 9 | EPHB1 | 1.94388114 |
| 10 | MAP3K2 | 1.91943743 |
| 11 | LMTK2 | 1.79069936 |
| 12 | FGFR4 | 1.75038413 |
| 13 | SIK1 | 1.73677819 |
| 14 | EEF2K | 1.68747580 |
| 15 | PKN2 | 1.66189842 |
| 16 | SCYL2 | 1.63749458 |
| 17 | MAP3K6 | 1.54995017 |
| 18 | MAP2K3 | 1.48308344 |
| 19 | TESK1 | 1.48109649 |
| 20 | NEK9 | 1.46742795 |
| 21 | NTRK1 | 1.40842681 |
| 22 | RET | 1.37480664 |
| 23 | RIPK4 | 1.33889697 |
| 24 | MYLK | 1.31754436 |
| 25 | DDR2 | 1.31565186 |
| 26 | CDK12 | 1.30314242 |
| 27 | STK38 | 1.30164121 |
| 28 | NTRK3 | 1.28718747 |
| 29 | JAK1 | 1.26829805 |
| 30 | FGFR3 | 1.26430971 |
| 31 | IRAK3 | 1.23691248 |
| 32 | CDC42BPA | 1.21612358 |
| 33 | TYK2 | 1.17743871 |
| 34 | PTK2 | 1.14810821 |
| 35 | TGFBR2 | 1.12890960 |
| 36 | MAP3K1 | 1.10885728 |
| 37 | MAP3K3 | 1.10576169 |
| 38 | EPHA3 | 1.08084876 |
| 39 | DMPK | 1.04363831 |
| 40 | AKT3 | 1.03711508 |
| 41 | ZAP70 | 1.02527700 |
| 42 | MARK2 | 0.99223528 |
| 43 | MAP3K13 | 0.99007258 |
| 44 | KSR1 | 0.98582834 |
| 45 | PAK6 | 0.97061933 |
| 46 | TRPM7 | 0.95037269 |
| 47 | WNK1 | 0.94315113 |
| 48 | PDGFRB | 0.91776887 |
| 49 | SMG1 | 0.91428490 |
| 50 | CLK1 | 0.91039786 |
| 51 | RAF1 | 0.89574446 |
| 52 | MTOR | 0.88884488 |
| 53 | PDPK1 | 0.87029038 |
| 54 | LATS2 | 0.85780509 |
| 55 | PAK2 | 0.85486513 |
| 56 | MET | 0.84713678 |
| 57 | SGK3 | 0.84554830 |
| 58 | MAP3K7 | 0.83896442 |
| 59 | PRKD2 | 0.83847566 |
| 60 | PRKD3 | 0.83597790 |
| 61 | MAPK12 | 0.81487461 |
| 62 | JAK2 | 0.80532321 |
| 63 | PTK6 | 0.76983459 |
| 64 | HIPK2 | 0.75362438 |
| 65 | CAMKK1 | 0.69948965 |
| 66 | TAOK2 | 0.66564193 |
| 67 | ROCK2 | 0.64810584 |
| 68 | BMX | 0.64343511 |
| 69 | MAP2K1 | 0.63168214 |
| 70 | LIMK1 | 0.61847686 |
| 71 | RPS6KA2 | 0.61143272 |
| 72 | PAK4 | 0.59829461 |
| 73 | MST1R | 0.58850092 |
| 74 | MOS | 0.58525380 |
| 75 | PDK1 | 0.58282373 |
| 76 | EIF2AK1 | 0.57912061 |
| 77 | PRKG2 | 0.56785728 |
| 78 | LRRK2 | 0.56444944 |
| 79 | JAK3 | 0.56246373 |
| 80 | EPHA2 | 0.55226167 |
| 81 | MAPK11 | 0.53940409 |
| 82 | ROCK1 | 0.51355161 |
| 83 | PRKD1 | 0.49447838 |
| 84 | MARK1 | 0.49018057 |
| 85 | FER | 0.47279321 |
| 86 | ARAF | 0.47248982 |
| 87 | TBK1 | 0.46556859 |
| 88 | PIK3CG | 0.46377454 |
| 89 | SGK494 | 0.44081842 |
| 90 | SGK223 | 0.44081842 |
| 91 | MAP3K8 | 0.43965554 |
| 92 | CAMKK2 | 0.43414326 |
| 93 | SGK2 | 0.42204899 |
| 94 | MAPK7 | 0.41172027 |
| 95 | MAPKAPK3 | 0.41009299 |
| 96 | MUSK | 0.37998007 |
| 97 | TESK2 | 0.36362418 |
| 98 | MAPK10 | 0.35111698 |
| 99 | BLK | 0.34483317 |
| 100 | PRKAA2 | 0.33705923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.52793406 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.27163905 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.82824972 |
| 4 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.73335364 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.72955053 |
| 6 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.56005906 |
| 7 | Focal adhesion_Homo sapiens_hsa04510 | 1.55616579 |
| 8 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.51955133 |
| 9 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.47873601 |
| 10 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.46634097 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.45651471 |
| 12 | Prion diseases_Homo sapiens_hsa05020 | 1.43961985 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.42023352 |
| 14 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.35867420 |
| 15 | Endometrial cancer_Homo sapiens_hsa05213 | 1.32194907 |
| 16 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.30562027 |
| 17 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.29727580 |
| 18 | Glioma_Homo sapiens_hsa05214 | 1.29374915 |
| 19 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.20872631 |
| 20 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19589205 |
| 21 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.18397380 |
| 22 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.17628873 |
| 23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.16766122 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.15457243 |
| 25 | Amoebiasis_Homo sapiens_hsa05146 | 1.13958866 |
| 26 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.11789418 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08609135 |
| 28 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.07873109 |
| 29 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.07843945 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.05585304 |
| 31 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04376452 |
| 32 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04088916 |
| 33 | Thyroid cancer_Homo sapiens_hsa05216 | 1.03784692 |
| 34 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.03596344 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.03353664 |
| 36 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.99930024 |
| 37 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.99380976 |
| 38 | Adherens junction_Homo sapiens_hsa04520 | 0.97107602 |
| 39 | Long-term potentiation_Homo sapiens_hsa04720 | 0.96608253 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96046625 |
| 41 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94484901 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93342803 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93020009 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92372507 |
| 45 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.92101462 |
| 46 | Endocytosis_Homo sapiens_hsa04144 | 0.91706464 |
| 47 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.88746224 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88474621 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 0.87456419 |
| 50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.87228387 |
| 51 | Bladder cancer_Homo sapiens_hsa05219 | 0.87063179 |
| 52 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.87017740 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86364015 |
| 54 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86045938 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85905773 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.84625325 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82470036 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.79022767 |
| 59 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78705430 |
| 60 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78466076 |
| 61 | Bile secretion_Homo sapiens_hsa04976 | 0.76905774 |
| 62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74737211 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.74259923 |
| 64 | Prostate cancer_Homo sapiens_hsa05215 | 0.73919454 |
| 65 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.73641199 |
| 66 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.73572456 |
| 67 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71459762 |
| 68 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71040403 |
| 69 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70775184 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70667217 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69075410 |
| 72 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.68641146 |
| 73 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66334174 |
| 74 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65406077 |
| 75 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65291545 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64974267 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.64685728 |
| 78 | Gap junction_Homo sapiens_hsa04540 | 0.64477928 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64293641 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64105177 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63525477 |
| 82 | Malaria_Homo sapiens_hsa05144 | 0.63371028 |
| 83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.62015575 |
| 84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.61054239 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.60732387 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.58833792 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58377315 |
| 88 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58327115 |
| 89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57993196 |
| 90 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56842466 |
| 91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56668587 |
| 92 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56653763 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56121358 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.56004901 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.53968317 |
| 96 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52792051 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52033358 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51265472 |
| 99 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50622052 |
| 100 | Shigellosis_Homo sapiens_hsa05131 | 0.50538651 |

